Corbus Pharmaceuticals Holdings, Inc. Foreign Currency Transaction Loss, before Tax
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Foreign Currency Transaction Loss, before Tax of $45.83 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ForeignCurrencyTransactionLossBeforeTax · last filed 2020-03-16
- Corbus Pharmaceuticals Holdings, Inc. foreign currency transaction loss, before tax for the quarter ending 2019-12-31 was -$69.82K, a 303.65% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. foreign currency transaction loss, before tax for the quarter ending 2019-09-30 was $116.25K.
- Corbus Pharmaceuticals Holdings, Inc. foreign currency transaction loss, before tax for the quarter ending 2019-06-30 was -$13.96K, a 144.46% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. foreign currency transaction loss, before tax for the quarter ending 2019-03-31 was $13.37K, a 44.65% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. foreign currency transaction loss, before tax for fiscal 2019 was $45.83K, a 34.94% decline from fiscal 2018.
- Corbus Pharmaceuticals Holdings, Inc. foreign currency transaction loss, before tax for fiscal 2018 was $70.45K.
- Corbus Pharmaceuticals Holdings, Inc. foreign currency transaction loss, before tax for fiscal 2017 was -$8.49K, a 160.24% decline from fiscal 2016.
- Corbus Pharmaceuticals Holdings, Inc. foreign currency transaction loss, before tax for fiscal 2016 was $14.09K.
| Period end | Foreign Currency Transaction Loss, before Tax 3 month | Foreign Currency Transaction Loss, before Tax 6 month | Foreign Currency Transaction Loss, before Tax 9 month | Foreign Currency Transaction Loss, before Tax 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$69.82K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $46.42K derived: sum of 2 quarters · filed 2020-03-16 | $32.46K derived: sum of 3 quarters · filed 2020-03-16 | $45.83K 10-K · filed 2020-03-16 |
| 2019-09-30 | $116.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $102.28K derived: sum of 2 quarters · filed 2019-11-07 | $115.65K 10-Q · filed 2019-11-07 | $149.94K derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-06-30 | -$13.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$591.00 10-Q · filed 2019-08-08 | $33.69K derived: sum of 3 quarters · filed 2020-03-16 | $29.20K derived: sum of 4 quarters · filed 2020-03-16 |
| 2019-03-31 | $13.37K 10-Q · filed 2019-05-09 | $47.66K derived: sum of 2 quarters · filed 2020-03-16 | $43.17K derived: sum of 3 quarters · filed 2020-03-16 | $74.58K derived: sum of 4 quarters · filed 2020-03-16 |
| 2018-12-31 | $34.28K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $29.79K derived: sum of 2 quarters · filed 2020-03-16 | $61.20K derived: sum of 3 quarters · filed 2020-03-16 | $70.45K 10-K · filed 2020-03-16 |
| 2018-09-30 | -$4.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $26.92K derived: sum of 2 quarters · filed 2019-11-07 | $36.16K 10-Q · filed 2019-11-07 | -$11.82K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $31.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $40.65K 10-Q · filed 2019-08-08 | -$7.33K derived: sum of 3 quarters · filed 2019-08-08 | $7.30K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $9.24K 10-Q · filed 2019-05-09 | -$38.74K derived: sum of 2 quarters · filed 2019-05-09 | -$24.10K derived: sum of 3 quarters · filed 2019-05-09 | -$13.51K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$47.98K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$33.35K derived: sum of 2 quarters · filed 2019-03-12 | -$22.75K derived: sum of 3 quarters · filed 2019-03-12 | -$8.49K 10-K · filed 2019-03-12 |
| 2017-09-30 | $14.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $25.23K derived: sum of 2 quarters · filed 2018-11-08 | $39.49K 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $10.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $24.86K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $14.27K 10-Q · filed 2018-05-10 | |||
| 2016-12-31 | $14.09K 10-K · filed 2018-03-12 | |||
| 2015-12-31 | -$1.98K 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |